Barriers to guideline-concordant use of bone modifying agents for prostate cancer.

Authors

A P. Mitchell
S Persaud
S Chimonas
A Salner
Paul Palyca MD, Lehigh Valley Health NetworkFollow
A Farooki
J Ostroff
M J. Morris

Publication/Presentation Date

2-2023

Published In/Presented At

Aaron Philip Mitchell et al.,

Barriers to guideline-concordant use of bone modifying agents for prostate cancer.. JCO 41, 68-68(2023).

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine, Hematology-Medical Oncology Division, Lehigh Valley Topper Cancer Institute

Document Type

Article